603079 Zhejiang Shengda Bio-Pharm
- 12.42
- +1.02+8.95%
Zhejiang Shengda Bio-Pharm News
Zhejiang Shengda Biopharmaceutical Co., Ltd. 2024 Employee Stock Ownership Plan
Legal Opinion of Zhejiang Tianze Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Zhejiang Shengda Biopharmaceutical Co., Ltd.
Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders of Zhejiang Shengda Biopharmaceutical Co., Ltd.
Zhejiang Shengda Biopharmaceutical Co., Ltd. 2024 Second Extraordinary General Meeting of Shareholders Meeting Materials
Announcement of Zhejiang Shengda Bio-pharm Co., Ltd. regarding the provision for asset impairment
Zhejiang Shengda Bio-Pharm Co., Ltd. Announcement on the Resolutions of the Employee Representative Assembly
Notice on the convening of the second extraordinary general meeting of shareholders in 2024 by Zhejiang Shengda Bio-pharmaceutical Co., Ltd.
zhejiang shengda bio-pharm's 2024 Employee Stock Ownership Plan (draft) Summary
zhejiang shengda bio-pharm's 2024 Employee Stock Ownership Plan (Draft)
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Zhejiang Shengda Biopharmaceutical Co., Ltd.
Legal Opinion of Zhejiang Tianze Law Firm on the 2023 Annual General Meeting of Shareholders of Zhejiang Shengda Biopharmaceutical Co., Ltd.
Zhejiang Shengda Biopharmaceutical Co., Ltd. Stock Trading Risk Warning Notice
Zhejiang Shengda Biopharmaceutical Co., Ltd. 2023 Annual General Meeting Meeting Meeting Materials
Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders of Zhejiang Shengda Biopharmaceutical Co., Ltd.
Legal Opinion of Zhejiang Tianze Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Zhejiang Shengda Biopharmaceutical Co., Ltd.
Special Report on Non-operating Capital Occupation and Other Related Capital Transactions of Zhejiang Shengda Biopharmaceutical Co., Ltd. in 2023
Zhejiang Shengda Biopharmaceutical Co., Ltd. 2023 Internal Control Evaluation Report
Zhejiang Shengda Biopharmaceutical Co., Ltd. Board of Directors Audit Committee Performance Report 2023
Zhejiang Shengda Biopharmaceutical Co., Ltd. selection and recruitment system for accounting firms
Report on the performance of supervisory duties of Tianjian Certified Public Accountants by the Audit Committee of the Board of Directors of Zhejiang Shengda Biopharmaceutical Co., Ltd. in 2023
Analysis
Price Target
No Data
No Data